
PTN
Healthcare · Biotechnology · $11.1M market cap
$6.23-0.34 (-5.2%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 13, 2026 | Time not confirmed | -0.32 | — | — |
| Sep 28, 2026 | Before the open | -1.12 | -1.11 | +0.9% |
| May 13, 2026 | Before the open | -0.82 | -0.37 | +54.9% |
| Feb 17, 2026 | Before the open | -1.47 | -2.86 | -94.6% |
| Nov 13, 2025 | Time not confirmed | — | 4.26 | — |
| May 14, 2025 | Before the open | -8.50 | -9.92 | -16.7% |
| Feb 13, 2025 | Before the open | -21.00 | -6.00 | +71.4% |
| Nov 14, 2024 | Before the open | -25.50 | -19.50 | +23.5% |
| Sep 26, 2024 | Before the open | -0.51 | -0.50 | +2.0% |
| May 15, 2024 | Before the open | -24.83 | -26.50 | -6.7% |
| Feb 14, 2024 | After the close | -10.17 | -28.00 | -175.3% |
| Nov 14, 2023 | Before the open | -20.50 | -24.00 | -17.1% |
| Sep 28, 2023 | Before the open | -0.56 | -0.91 |
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity completed Phase 2 clinical trial;…
| -62.5% |
| May 15, 2023 | After the close | -23.00 | -31.50 | -37.0% |
| Feb 14, 2023 | After the close | -34.83 | -7.70 | +77.9% |
| Nov 14, 2022 | Before the open | -59.75 | -43.00 | +28.0% |
| Sep 22, 2022 | Before the open | -0.81 | -1.34 | -65.4% |
| May 16, 2022 | After the close | -41.67 | -37.50 | +10.0% |
| Feb 14, 2022 | After the close | -37.50 | -50.00 | -33.3% |
| Nov 15, 2021 | Before the open | -0.83 | -0.75 | +9.6% |
| Sep 28, 2021 | After the close | -37.50 | -75.00 | -100.0% |
| May 14, 2021 | After the close | -41.67 | -25.00 | +40.0% |
| Feb 16, 2021 | After the close | -29.17 | -50.00 | -71.4% |
| Nov 16, 2020 | After the close | -12.50 | -25.00 | -100.0% |
| Sep 25, 2020 | After the close | -0.58 | -0.75 | -29.3% |
| May 11, 2020 | After the close | -25.00 | -25.00 | 0.0% |
| Feb 11, 2020 | Before the open | -12.50 | -25.00 | -100.0% |
| Nov 12, 2019 | After the close | -0.50 | -0.50 | 0.0% |
| Sep 12, 2019 | Before the open | -37.50 | 287.50 | +866.7% |
| May 9, 2019 | Before the open | -37.50 | -37.50 | 0.0% |
| Feb 11, 2019 | After the close | -37.50 | -25.00 | +33.3% |
| Nov 9, 2018 | After the close | -43.75 | -37.50 | +14.3% |
| Sep 13, 2018 | Before the open | -0.08 | 1.50 | +1975.0% |
| May 14, 2018 | After the close | -50.00 | -0.00 | +100.0% |
| Feb 12, 2018 | Before the open | -225.00 | 15.63 | +106.9% |